Like most 4-year-old girls, Nora was full of life — happy, energetic and always on the go. Nothing seemed out of the ordinary until her...
Nora’s Journey With Cancer: The Spirit of a Fighter
read more
Featured Blogs
Childhood Cancer Awareness Month 2025
September is Childhood Cancer Awareness Month — and this year, Rally Foundation for Childhood Cancer Research is celebrating 20 years of...
What’s One Hour of Your Time Worth?
Some people think of volunteering as a nice gesture. But in the fight against childhood cancer, it’s a lifeline. Volunteers are the...
What is Ewing Sarcoma?
Ewing Sarcoma Defined Ewing sarcoma is a cancerous bone tumor that affects children, adolescent and young adults—usually developing during...
What is Rhabdomyosarcoma?
Rhabdomyosarcoma (RMS) is a type of soft tissue cancer that most commonly affects children and adolescents. It’s often found in skeletal...
What Is Osteosarcoma?
Osteosarcoma is the most common type of bone cancer in children and adolescents. The tumor often originates in the long bones of the body,...
Rally Is Proud to Award $300,000 to These Outside the Box Grant Recipients!
Breakthroughs happen — in science, in medicine and especially in childhood cancer research — with outside-the-box thinking. At Rally...
Rally Is Excited to Announce $1.2M in Funding for Career Development Awards
At Rally, we believe that innovative research begins with innovative researchers. That’s why we are thrilled to announce the recipients of...
Rally Announces $800K in Awards to Consortium Grants
We are thrilled to share that Rally Foundation has awarded a total of $800,000 in funding for Consortium Grants this year. So, what...
Rally Foundation Announces More Than $1M for Independent Investigator Grants
Rally is thrilled to announce that $1,087,500 has been awarded through this year’s Independent Investigator Grants — supporting innovative...
$650,000 for Rally-Funded Young Investigator Grants
We’re delighted to announce the $650,000 awarded for this year’s Young Investigator Grants — supporting the next generation of childhood...
Rally Is Thrilled to Announce $600,000 Awarded to Our 2025 Postdoctoral and Clinical Research Fellow Grants
At Rally, we know the future of pediatric cancer research lies in the hands of the next generation of researchers. Many childhood cancer...
Rally Foundation Awards $5.5M for a Record Number of Grants to 75 Childhood Cancer Researchers
In 2025, Rally Foundation for Childhood Cancer Research (Rally) is thrilled to award a total of $5.5 million in childhood cancer research...
Five Pediatric Cancer Bills Cut From the 2025 Budget
Your Voice Matters Now More Than Ever We were so close to an epic year for childhood cancer. We had six bills that were in the end of year...
Dean’s Letter – December 2024
I love seeing pictures of our Rally Kids. But this one of 10-year-old #RallyKid Caroline hugging her older brother, Jack, hit me right in...
Featured Blogs
What Is a Postdoctoral and Clinical Research Fellow Grant?
Before we get to that, let’s first address the difference between a postdoctoral fellow and a clinical research fellow. It can definitely be confusing. A postdoctoral fellow, also called a postdoc, is someone who completed a Ph.D. program and is now conducting research under the guidance of a principal investigator (mentor) with the goal of one day having their own lab. A clinical research fellow is someone who graduated from medical school and completed their residency. The fellowship...
What is Lymphoma?
Lymphoma is a cancer of the body’s lymphatic (lymph) system which is essential to the immune system. The lymphatic system is made up of a type of white blood cells also known as lymphocytes which flow throughout the whole body. These lymphocytes fight infections throughout the body, so when cancerous cells begin to grow they can quickly spread through the entire lymph system. This then makes it difficult for the immune system to work properly. Early symptoms of lymphomas usually begin with a...
What Is the Link Between Down Syndrome and Childhood Cancer?
Let’s begin by explaining Down syndrome Down syndrome (DS) occurs in about one in every 700 births worldwide. There is a small change during early fetal development that leads to an extra copy of chromosome 21, which is why DS is also known as trisomy 21. People with DS have unique, recognizable physical characteristics and may experience some developmental delays, though these can vary widely from person to person. Children with Down syndrome have a unique relationship with cancer. That extra...
What is Chronic Myeloid Leukemia (CML)?
Chronic myeloid leukemia (CML) is a type of blood cancer that causes an overproduction of white blood cells. These cells grow abnormally and can build up in the blood and bone marrow, leaving less room for healthy white and red blood cells as well as platelets. CML is commonly associated with a genetic mutation called the Philadelphia chromosome. While CML is very rare in children, with about 150 pediatric cases in the U.S. each year, it’s often more aggressive in kids than it is in adults....
What is Neuroblastoma?
Neuroblastoma is a cancerous tumor that develops in the nervous system of babies and young children. It can also occur, rarely, in adolescents. A neuroblastoma tumor often affects immature nerve tissue called neuroblasts. The most common area for neuroblastoma to appear is in the adrenal glands, which sit above the kidneys. Adrenal glands produce hormones that control body functions such as digestion, blood pressure, breathing and heart rate. Neuroblastoma can also begin in other areas of the...
What is Atypical Teratoid/Rhabdoid Tumor (AT/RT)?
Atypical Teratoid/Rhabdoid Tumor (AT/RT) is a rare and fast-growing tumor that typically originates in the brain and spinal cord. These tumors most often occur in the part of the brain called the cerebellum, which controls movement and balance, or in the brain stem, which controls vital functions like breathing and heart rate. AT/RT mainly occurs in children under the age of three, but it can occur in older children and very rarely in adults. AT/RT is found in fewer than 3% of children with...